Nuveen Asset Management, LLC Royalty Pharma PLC Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 935,799 shares of RPRX stock, worth $23.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

935,799

Previous 932,441 0.36%

Holding current value

$23.4 Million

Previous $24.6 Million 7.67%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $86,065 - $98,288	3,358 Added 0.36%	935,799 $26.5 Million
Q2 2024 Aug 09, 2024	SELL	$26.26 - $29.9 $1.19 Million - $1.35 Million	-45,265 Reduced 4.63%	932,441 $24.6 Million
Q1 2024 May 13, 2024	SELL	$27.46 - $31.33 $734,692 - $838,234	-26,755 Reduced 2.66%	977,706 $29.7 Million
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $702,375 - $783,037	-26,798 Reduced 2.6%	1,004,461 $28.2 Million
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $293,928 - $351,236	-11,193 Reduced 1.07%	1,031,259 $28 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $1.06 Million - $1.31 Million	35,919 Added 3.57%	1,042,452 $32 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $334,974 - $402,746	-10,222 Reduced 1.01%	1,006,533 $36.3 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $1.04 Million - $1.17 Million	26,617 Added 2.69%	1,016,755 $40.2 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $382,449 - $428,193	9,590 Added 0.98%	990,138 $39.8 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $2.37 Million - $2.79 Million	63,117 Added 6.88%	980,548 $41.2 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $242,703 - $274,968	6,479 Added 0.71%	917,431 $35.7 Million
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $2.69 Million - $3.25 Million	-76,583 Reduced 7.75%	910,952 $36.3 Million
Q3 2021 Nov 12, 2021	SELL	$36.14 - $42.24 $7.49 Million - $8.76 Million	-207,347 Reduced 17.35%	987,535 $35.7 Million
Q2 2021 Aug 16, 2021	SELL	$39.85 - $46.63 $147,644 - $172,764	-3,705 Reduced 0.31%	1,194,882 $49 Million
Q1 2021 May 17, 2021	BUY	$42.34 - $52.82 $33.6 Million - $41.9 Million	793,209 Added 195.67%	1,198,587 $52.3 Million
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $5.18 Million - $7.18 Million	143,379 Added 54.73%	405,378 $20.3 Million
Q3 2020 Nov 16, 2020	BUY	$38.56 - $48.36 $10.1 Million - $12.7 Million	261,999 New	261,999 $11 Million

Others Institutions Holding RPRX

# of Institutions

414

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.9B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Royalty Pharma PLC Transaction History